Highbridge Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-31,541
Closed -$2.44M 416
2018
Q3
$2.44M Buy
+31,541
New +$2.38M 0.06% 313
2018
Q1
Sell
-205,430
Closed -$16.3M 1370
2017
Q4
$14.7M Buy
205,430
+197,564
+2,512% +$15M 0.26% 96
2017
Q3
$637K Sell
7,866
-218,366
-97% -$16.7M 0.01% 795
2017
Q2
$16M Buy
+226,232
New +$15.1M 0.24% 108
2017
Q1
Sell
-422,835
Closed -$30.3M 1517
2016
Q4
$30.3M Buy
422,835
+53,281
+14% +$3.96M 0.54% 37
2016
Q3
$29.2M Sell
369,554
-189,619
-34% -$15.4M 0.46% 40
2016
Q2
$46.6M Buy
559,173
+516,281
+1,204% +$45.8M 0.76% 18
2016
Q1
$3.94M Sell
42,892
-672,600
-94% -$60.7M 0.07% 346
2015
Q4
$72.4M Buy
715,492
+73,380
+11% +$7.64M 1.1% 3
2015
Q3
$63M Buy
642,112
+190,983
+42% +$21.2M 0.97% 7
2015
Q2
$52.8M Sell
451,129
-276,276
-38% -$30.2M 0.67% 21
2015
Q1
$71.4M Sell
727,405
-20,738
-3% -$2.11M 0.98% 3
2014
Q4
$70.5M Buy
748,143
+399,554
+115% +$41.3M 0.9% 5
2014
Q3
$37.1M Buy
348,589
+341,803
+5,037% +$33.5M 0.49% 52
2014
Q2
$563K Sell
6,786
-234,674
-97% -$18.3M 0.01% 714
2014
Q1
$17.1M Buy
241,460
+234,164
+3,209% +$18.4M 0.22% 122
2013
Q4
$548K Buy
+7,296
New +$508K 0.01% 652
2013
Q3
Sell
-8,595
Closed -$441K 1372
2013
Q2
$441K Buy
+8,595
New +$448K ﹤0.01% 920

Other funds holding GILD

Highbridge Capital Management's GILD Position: Q4 2018 in Review

Highbridge Capital Management sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 31,541 shares — an estimated $2.44M sold.

Highbridge Capital Management first reported a position in GILD in Q2 2013 and held it in 18 quarters. The position peaked at $72.4M in Q4 2015. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Highbridge Capital Management reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 31,541 Gilead Sciences shares in Q4 2018, an estimated $2.44M.
  • Highbridge Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 18 quarters.
  • Highbridge Capital Management's Gilead Sciences position peaked at $72.4M in Q4 2015.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.